Anavex Life Sciences Corp (AVXL)

[tradeherpete]

You’re right georgejjl, Thank you. 23% is about 72 responders so spitballing might be about right.

And 12% of 340 is 40 SuperHiemers.

Don't expect any super responders from the placebo cohort, which is approximately 169 from the 509 participants.

So, 60 super responders from the 340 participants taking Blarcamesine each and every day would be 60/340=17.6%, which is lower than I expect.
I expect approximately 23% super responders from the Phase 2b/3 trial.